BXRX

Baudax Bio (BXRX)

Baudax Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BXRX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/11/16	07:25	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:BXRX	Baudax Bio Inc
2023/11/16	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/10/25	20:57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/10/13	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/10/12	05:47	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BXRX	Baudax Bio Inc
2023/10/10	20:00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BXRX	Baudax Bio Inc
2023/10/06	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/09/29	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/09/26	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BXRX	Baudax Bio Inc
2023/09/26	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BXRX	Baudax Bio Inc
2023/09/22	06:30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:BXRX	Baudax Bio Inc
2023/09/22	05:48	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:BXRX	Baudax Bio Inc
2023/09/08	06:16	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BXRX	Baudax Bio Inc
2023/09/08	05:10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BXRX	Baudax Bio Inc
2023/09/08	05:06	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:BXRX	Baudax Bio Inc
2023/09/06	06:24	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:BXRX	Baudax Bio Inc
2023/09/06	05:13	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BXRX	Baudax Bio Inc
2023/09/06	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/08/26	05:01	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:BXRX	Baudax Bio Inc
2023/08/25	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/08/25	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/08/25	06:05	Edgar (US Regulatory)	Form 8-A12G - Registration of securities [Section 12(g)]	NASDAQ:BXRX	Baudax Bio Inc
2023/08/21	21:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BXRX	Baudax Bio Inc
2023/08/21	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/08/19	05:40	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BXRX	Baudax Bio Inc
2023/08/17	21:05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BXRX	Baudax Bio Inc
2023/08/16	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BXRX	Baudax Bio Inc
2023/08/15	20:30	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:BXRX	Baudax Bio Inc
2023/08/10	06:28	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BXRX	Baudax Bio Inc
2023/08/10	06:27	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:BXRX	Baudax Bio Inc